menu search

Eagle Pharmaceuticals Provides Business Update and Guidance for 2023

Eagle Pharmaceuticals Provides Business Update and Guidance for 2023
WOODCLIFF LAKE, N.J., Jan. 10, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today provided a business update and guidance for 2023. Highlights: During the 12 months ended September 30, 2022, Eagle recorded net income of $21.3 million or $1.63 per diluted share and adjusted EBITDA of $125.6 million and […] The post Eagle Pharmaceuticals Provides Business Update and Guidance for 2023 appeared first on ForexTV... Read More
Posted: Jan 10 2023, 19:00
Author Name: forextv
Views: 110831

Search within

Pages Search Results: